NMC
MDT icon

Nine Masts Capital’s Medtronic MDT Stock Holding History

Nine Masts Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,643
Closed -$703K – 101
2025
Q2 		$666K Buy
+7,643
New +$648K 0.24% 45
2025
Q1 		– Sell
-15,112
Closed -$1.35M – 132
2024
Q4 		$1.21M Buy
+15,112
New +$1.31M 0.21% 46
2017
Q4 		– Sell
-3,790
Closed -$304K – 283
2017
Q3 		$295K Buy
+3,790
New +$315K 0.04% 72

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nine Masts Capital's MDT Position: Q3 2025 in Review

Nine Masts Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 7,643 shares — an estimated $703K sold.

Nine Masts Capital first reported a position in MDT in Q3 2017 and held it in 3 quarters. The position peaked at $1.21M in Q4 2024. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Nine Masts Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Nine Masts Capital sold 7,643 Medtronic shares in Q3 2025, an estimated $703K.
  • Nine Masts Capital first reported a position in Medtronic in Q3 2017 and held it in 3 quarters.
  • Nine Masts Capital's Medtronic position peaked at $1.21M in Q4 2024.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Nine Masts Capital's 13F filing for Q3 2025, filed 13 Nov 2025.